1. Home
  2. ATLN vs OPP Comparison

ATLN vs OPP Comparison

Compare ATLN & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATLN
  • OPP
  • Stock Information
  • Founded
  • ATLN N/A
  • OPP 2010
  • Country
  • ATLN
  • OPP United States
  • Employees
  • ATLN 7
  • OPP N/A
  • Industry
  • ATLN
  • OPP Finance/Investors Services
  • Sector
  • ATLN
  • OPP Finance
  • Exchange
  • ATLN NYSE
  • OPP Nasdaq
  • Market Cap
  • ATLN 248.2M
  • OPP 200.8M
  • IPO Year
  • ATLN N/A
  • OPP N/A
  • Fundamental
  • Price
  • ATLN $5.32
  • OPP $8.27
  • Analyst Decision
  • ATLN
  • OPP
  • Analyst Count
  • ATLN 0
  • OPP 0
  • Target Price
  • ATLN N/A
  • OPP N/A
  • AVG Volume (30 Days)
  • ATLN N/A
  • OPP 108.0K
  • Earning Date
  • ATLN N/A
  • OPP 01-01-0001
  • Dividend Yield
  • ATLN N/A
  • OPP 14.41%
  • EPS Growth
  • ATLN N/A
  • OPP N/A
  • EPS
  • ATLN N/A
  • OPP N/A
  • Revenue
  • ATLN N/A
  • OPP N/A
  • Revenue This Year
  • ATLN N/A
  • OPP N/A
  • Revenue Next Year
  • ATLN N/A
  • OPP N/A
  • P/E Ratio
  • ATLN N/A
  • OPP N/A
  • Revenue Growth
  • ATLN N/A
  • OPP N/A
  • 52 Week Low
  • ATLN N/A
  • OPP $7.26
  • 52 Week High
  • ATLN N/A
  • OPP $8.83
  • Technical
  • Relative Strength Index (RSI)
  • ATLN N/A
  • OPP 31.65
  • Support Level
  • ATLN N/A
  • OPP $8.43
  • Resistance Level
  • ATLN N/A
  • OPP $8.75
  • Average True Range (ATR)
  • ATLN 0.00
  • OPP 0.09
  • MACD
  • ATLN 0.00
  • OPP -0.01
  • Stochastic Oscillator
  • ATLN 0.00
  • OPP 4.00

About ATLN ATLANTIC INTERNATIONAL CORP

Atlantic International Corp formerly SeqLL Inc is a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property across multiple omics fields. The company leverages its expertise with the True Single Molecule Sequencing platform to empower scientists and researchers with improved genetic tools to greater understand the molecular mechanisms of disease that is essential to the continued development of new breakthroughs in genomic medicine, and that hopefully address the critical concerns involved with precision medicine.

About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.

RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.

Share on Social Networks: